IP Library Granted Patent US 10,369,366
Granted Patent B2
US 10,369,366 · App. 15/726,971 · Granted Aug 6, 2019

Implantable electrostimulator for improving blood flow

Inventors: Gur Oron (Tel Aviv, IL); Yossi Gross (Moshav Mazor, IL); Bar Eytan (Gedera, IL); Eran Benjamin (Tel-Aviv, IL); Karin Aharonson-Raz (Karmey Yosef, IL)
Assignee: BLUEWIND MEDICAL LTD.
A61N1/36135A61N1/3606A61N1/3756A61N1/37205A61N1/3787
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,366
App. No.
15/726,971
Granted
Aug 6, 2019
Kind
B2
Abstract

Apparatus includes an implant and an introducer. The implant includes an injectable housing, an electrode disposed on an outer surface of the housing, and circuitry. The circuitry is configured to alternate between a first mode in which the circuitry drives the electrode to apply a first electrical current having a frequency of 1-100 Hz, and a second mode in which the implant applies a second electrical current having a frequency of 1-10 kHz. The introducer includes a tube that defines a lumen and is percutaneously-advanceable into tissue of the subject, the lumen being dimensioned to at least temporarily house the implant. The introducer is configured to deploy the implant from a distal end of the lumen by moving the implant and the distal end of the lumen relative to each other. Other embodiments are also described.

Claims (23)

1. Apparatus for treating a subject who suffers from both peripheral artery occlusive disease and polyneuropathy, the apparatus comprising:

an implant, comprising:

an injectable housing,

an electrode disposed on an outer surface of the housing, and

circuitry, configured:

(i) with a first mode in which the circuitry drives the electrode to apply a first electrical current having a frequency of 1-100 Hz,

(ii) with a second mode in which the implant applies a second electrical current having a frequency of 1-10 kHz, and

(iii) to alternate the implant between the first mode and the second mode; and

an introducer:

comprising a tube defining a lumen, the tube being percutaneously-advanceable into tissue of the subject, and the lumen dimensioned to at least temporarily house the implant, and

configured to deploy the implant from a distal end of the lumen by moving the implant and the distal end of the lumen relative to each other.

2. The apparatus according to claim 1 , wherein the implant further comprises a temperature sensor, configured to detect a temperature of the tissue, and wherein the circuitry is configured to drive the electrode to apply the first electrical current in response to the detected temperature being below a threshold temperature.

3. The apparatus according to claim 1 , wherein the implant further comprises a pressure sensor, configured to detect a pressure within the tissue, and the circuitry is configured to drive the electrode to apply the first electrical current at least in part responsively to the detected pressure.

4. The apparatus according to claim 3 , wherein the pressure comprises a pulse pressure, and the circuitry is configured to drive the electrode to apply the first electrical current at least in part responsively to the detected pulse pressure.

5. The apparatus according to claim 1 , wherein the implant further comprises an oximeter, configured to detect an oxygen saturation within the tissue, and the circuitry is configured to drive the electrode to apply the first electrical current at least in part responsively to the detected oxygen saturation.

6. The apparatus according to claim 1 , wherein the circuitry is configured to remain in the first mode for a first-mode duration of 1-30 minutes.

7. The apparatus according to claim 6 , wherein the circuitry is configured to remain in the first mode for a first-mode duration of 2-20 minutes.

8. The apparatus according to claim 7 , wherein the circuitry is configured to remain in the first mode for a first-mode duration of 5-15 minutes.

9. The apparatus according to claim 1 , wherein the circuitry is configured to remain in the second mode for a second-mode duration of 1-30 minutes.

10. The apparatus according to claim 9 , wherein the circuitry is configured to remain in the second mode for a second-mode duration of 2-20 minutes.

11. The apparatus according to claim 10 , wherein the circuitry is configured to remain in the second mode for a second-mode duration of 5-15 minutes.

12. The apparatus according to claim 1 , wherein the circuitry is configured to remain in the first mode for a first-mode duration, and to remain in the second mode for a second-mode duration that is the same as the first-mode duration.

13. The apparatus according to claim 1 , wherein the circuitry is configured to remain in the first mode for a first-mode duration, and to remain in the second mode for a second-mode duration that is different from the first-mode duration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2022
From: ORON, GUR; GROSS, YOSSI; EYTAN, BAR; BENJAMIN, ERAN; AHARONSON-RAZ, KARIN; PLOTKIN, ANTON
To: BLUEWIND MEDICAL LTD.
Reel/Frame 059540/0786 →
Continuity (2)
Continuation 14735741 · Jun 10, 2015
Related Publication 20180028816A1 · Feb 1, 2018
Cited By (3)
US 12,226,634 US 12,343,537 US 12,420,098